Metsera (MTSR) shares rose sharply in their trading debut on Nasdag Friday after the company priced its initial public offering of almost 15.3 million shares at $18 per share.
The stock was up about 45% at $26.10 in recent trading after opening at $25.50.
The clinical-stage biotechnology company granted its underwriters a 30-day option to buy up to roughly 2.3 million additional shares. It expects to close the offering Monday.
BofA Securities, Goldman Sachs, Evercore ISI, Guggenheim Securities and Cantor are joint bookrunners for the offering.
Price: 26.31, Change: +8.31, Percent Change: +46.17
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。